Clinical Trial Update: Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the efficacy of Secukinumab versus Ustekinumab in patients with chronic plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Cosentyx (secukinumab)
• Stelara (ustekinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Plaque Type Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2017-07-21